Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb

LONDON, April 25, 2014 /PRNewswire/ --

Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Nokia OYJ (NYSE: NOK), Boston Scientific Corp. (NYSE: BSX), Merck & Co. Inc. (NYSE: MRK) and Bristol-Myers Squibb Co. (NYSE: BMY). Full earnings notes on NOK, BSX, MRK and BMY can be downloaded upon signing up at:

http://www.earningssource.com/1714-register

Nokia OYJ is scheduled to release its first-quarter FY 2014 results on Tuesday, April 29, 2014, at 1:00 am (EST). Analysts have predicted net earnings for the company at $0.03 a share for the reporting quarter. Sign up today to read free research on NOK at:

http://www.earningssource.com/1714-NOK-25Apr2014.pdf

On Tuesday, April 29, 2014, Boston Scientific Corp. will be releasing its Q1 FY 2014 earnings report. The company reported earnings of $0.10 a share in the year-ago same quarter. In the previous quarter, the company recorded earnings of $0.13 a share, in-line with the market expectation. During the last one year, Boston Scientific Corp.'s EPS has grown 96.89% and analysts at Wall Street have projected an EPS of $0.11 for the reporting quarter. As of Thursday, April 24, 2014, the company's P/E ratio stood at 30.83. Sign up today to read free research on BSX at:

http://www.earningssource.com/1714-BSX-25Apr2014.pdf

Merck & Co. Inc. will announce its first-quarter FY 2014 earnings on Tuesday, April 29, 2014, before the market opens. The company's Q1 FY 2013 net earnings stood at $0.85 per share. During the previous quarter earnings release, Merck & Co. Inc. had reported net profit of $0.88 per share, which was slightly below the analysts' estimate of $0.89 per share. In the last one year, the company's earnings per share has declined 26.60%. In the current quarter, Merck & Co. Inc. is expected to report earnings of $0.79 a share. At the last close on Thursday, April 24, 2014, shares of the company were trading at a P/E ratio of 16.53. Sign up today to read free research on MRK at:

http://www.earningssource.com/1714-MRK-25Apr2014.pdf

Before the opening bell on Tuesday, April 29, 2014, Bristol-Myers Squibb Co. will report its first-quarter FY 2014 earnings. The company is expected to post net earnings of $0.43 a share, above the reported earnings of $0.38 a share in the year-ago same quarter. In the last quarter, the company posted earnings of $0.51 a share, which was above the analysts' projection of $0.43 a share. Bristol-Myers Squibb Co.'s EPS has risen by 33.33% in the last one year. The company's P/E ratio stood at 30.23 on Thursday, April 24, 2014. Sign up today to read free research on BMY at:

http://www.earningssource.com/1714-BMY-25Apr2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.earningssource.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.earningssource.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.earningssource.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Earnings Source. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Earnings Source in this article or report according to the procedures outlined by Earnings Source. Earnings Source is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Earnings Source makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Earnings Source is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Earnings Source whatsoever for any direct, indirect or consequential loss arising from the use of this document. Earnings Source expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Earnings Source does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Earnings Source